SCHEMBL2348525

SCHEMBL2348525

CC(=O)COC(=O)C1CC2C=CC1C2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.53
HPGD P15428 1/20 0.53
KMT2A Q03164 3/20 0.52
RAB9A P51151 1/20 0.52
POLB P06746 3/20 0.52
HSD17B10 Q99714 2/20 0.50
APEX1 P27695 1/20 0.50
RECQL P46063 1/20 0.50
BLM P54132 1/20 0.50
ESR2 Q92731 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
LMNA P02545 2/20 0.46
KDM4E B2RXH2 2/20 0.46
MAPK1 P28482 2/20 0.45
MAPT P10636 1/20 0.42
MEN1 O00255 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14639862 1.00 ALDH1A1 (0.53) ALDH1A1HPGDKMT2ARAB9APOLB
SCHEMBL12376498 0.85 ALDH1A1 (0.56) ALDH1A1HPGDKMT2ARAB9APOLB
SCHEMBL11908866 0.84 ALDH1A1 (0.57) ALDH1A1HPGDKMT2ARAB9APOLB
SCHEMBL200507 0.83 ALDH1A1 (0.49) ALDH1A1HPGDKMT2ARAB9APOLB
SCHEMBL2754655 0.83 ALDH1A1 (0.49) ALDH1A1HPGDKMT2ARAB9APOLB
SCHEMBL11702317 0.83 ALDH1A1 (0.49) ALDH1A1HPGDKMT2ARAB9APOLB
SCHEMBL31178091 0.83 ALDH1A1 (0.49) ALDH1A1HPGDKMT2ARAB9APOLB
SCHEMBL2754654 0.83 ALDH1A1 (0.49) ALDH1A1HPGDKMT2ARAB9APOLB
SCHEMBL29452889 0.83 ALDH1A1 (0.49) ALDH1A1HPGDKMT2ARAB9APOLB
SCHEMBL11908076 0.83 ALDH1A1 (0.52) ALDH1A1HPGDKMT2ARAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078079-A1 FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES OSMO LABS PBC (US) 2026-03-19 US disclosed
EP-1741705-B1 Fluorinated cyclic structure-bearing silicon compounds and silicone resins, resist compositions using the same, and patterning process SHINETSU CHEMICAL CO (JP) 2011-08-24 EP disclosed
EP-1741705-B1 Fluorinated cyclic structure-bearing silicon compounds and silicone resins, resist compositions using the same, and patterning process SHINETSU CHEMICAL CO (JP) 2011-08-24 EP disclosed
US-7638256-B2 Fluorinated cyclic structure-bearing silicon compounds and silicone resins, resist compositions using the same, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-12-29 US disclosed
US-7638256-B2 Fluorinated cyclic structure-bearing silicon compounds and silicone resins, resist compositions using the same, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-12-29 US disclosed
US-7638256-B2 Fluorinated cyclic structure-bearing silicon compounds and silicone resins, resist compositions using the same, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-12-29 US disclosed
US-20070009832-A1 Fluorinated cyclic structure-bearing silicon compounds and silicone resins, resist compositions using the same, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2007-01-11 US disclosed
US-20070009832-A1 Fluorinated cyclic structure-bearing silicon compounds and silicone resins, resist compositions using the same, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2007-01-11 US disclosed
US-20070009832-A1 Fluorinated cyclic structure-bearing silicon compounds and silicone resins, resist compositions using the same, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2007-01-11 US disclosed
EP-1741705-A1 Fluorinated cyclic structure-bearing silicon compounds and silicone resins, resist compositions using the same, and patterning process Shin-Etsu Chemical Co., Ltd. (JP) 2007-01-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078079-A1 FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES CBR1, CBR3, TAS2R1 ALDH1A1 804/4885HPGD 709/4885KMT2A 3953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.